Foliumzuursuppletiebeleid bij zwangerschap werkt, maar moet beter.

Denhard J. de Smid; Lolkje T W de Jong-van den Berg; Martina C. Cornel

Foliumzuursuppletiebeleid bij zwangerschap werkt, maar moet beter.

Translated title of the contribution: [Peri-pregnancy folic acid supplementation must be improved].

Denhard J. de Smid^*, Lolkje T W de Jong-van den Berg, Martina C. Cornel

^*Corresponding author for this work

Human genetics

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

The correct usage of folic acid (FA) supplements to prevent neural tube defects (NTDs) increased from 28% in 1996 to 50% in 2005 and remained stable until 2009. Recent data from national birth defect registries show a decrease of NTD prevalence from 13.2 (per 10,000) in 1997 to 8.3 in 2005 and stabilization up to 2009. It is estimated that between 2005 and 2009 FA supplementation prevented 583 NTD cases. The medical costs thus averted are € 75 M. If the correct usage of FA were to be increased to 70%, another 34 cases per year could be prevented. Part of the gain from continued prevention and other averted costs should be invested beforehand in the promotion of FA supplement usage.

Translated title of the contribution	[Peri-pregnancy folic acid supplementation must be improved].
Original language	Dutch
Journal	Nederlands Tijdschrift voor Geneeskunde
Volume	156
Issue number	41
Publication status	Published - 1 Dec 2012

Cite this

@article{c46cb1e80a4940fcb7f7e3a8da65343d,

title = "Foliumzuursuppletiebeleid bij zwangerschap werkt, maar moet beter.",

abstract = "The correct usage of folic acid (FA) supplements to prevent neural tube defects (NTDs) increased from 28% in 1996 to 50% in 2005 and remained stable until 2009. Recent data from national birth defect registries show a decrease of NTD prevalence from 13.2 (per 10,000) in 1997 to 8.3 in 2005 and stabilization up to 2009. It is estimated that between 2005 and 2009 FA supplementation prevented 583 NTD cases. The medical costs thus averted are € 75 M. If the correct usage of FA were to be increased to 70%, another 34 cases per year could be prevented. Part of the gain from continued prevention and other averted costs should be invested beforehand in the promotion of FA supplement usage.",

author = "{de Smid}, {Denhard J.} and {de Jong-van den Berg}, {Lolkje T W} and Cornel, {Martina C.}",

year = "2012",

month = dec,

day = "1",

language = "Dutch",

volume = "156",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",

publisher = "Bohn Stafleu van Loghum",

number = "41",

}

TY - JOUR

T1 - Foliumzuursuppletiebeleid bij zwangerschap werkt, maar moet beter.

AU - de Smid, Denhard J.

AU - de Jong-van den Berg, Lolkje T W

AU - Cornel, Martina C.

PY - 2012/12/1

Y1 - 2012/12/1

N2 - The correct usage of folic acid (FA) supplements to prevent neural tube defects (NTDs) increased from 28% in 1996 to 50% in 2005 and remained stable until 2009. Recent data from national birth defect registries show a decrease of NTD prevalence from 13.2 (per 10,000) in 1997 to 8.3 in 2005 and stabilization up to 2009. It is estimated that between 2005 and 2009 FA supplementation prevented 583 NTD cases. The medical costs thus averted are € 75 M. If the correct usage of FA were to be increased to 70%, another 34 cases per year could be prevented. Part of the gain from continued prevention and other averted costs should be invested beforehand in the promotion of FA supplement usage.

AB - The correct usage of folic acid (FA) supplements to prevent neural tube defects (NTDs) increased from 28% in 1996 to 50% in 2005 and remained stable until 2009. Recent data from national birth defect registries show a decrease of NTD prevalence from 13.2 (per 10,000) in 1997 to 8.3 in 2005 and stabilization up to 2009. It is estimated that between 2005 and 2009 FA supplementation prevented 583 NTD cases. The medical costs thus averted are € 75 M. If the correct usage of FA were to be increased to 70%, another 34 cases per year could be prevented. Part of the gain from continued prevention and other averted costs should be invested beforehand in the promotion of FA supplement usage.

UR - http://www.scopus.com/inward/record.url?scp=84871916885&partnerID=8YFLogxK

M3 - Article

C2 - 23062252

AN - SCOPUS:84871916885

SN - 0028-2162

VL - 156

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

IS - 41

ER -

Foliumzuursuppletiebeleid bij zwangerschap werkt, maar moet beter.

Abstract

Other files and links

Cite this